Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Intraventricular Septal Defects

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Intraventricular Septal Defects in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Increased risk of ventricular septal defect was found to be associated with consumption of cough and cold remedies [pre-conception OR 2."1.32A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England. ( Bateman, DN; Dickinson, D; Matthews, JN; McElhatton, PR; O'Keeffe, M; Thomas, SH; Wren, C, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bateman, DN1
McElhatton, PR1
Dickinson, D1
Wren, C1
Matthews, JN1
O'Keeffe, M1
Thomas, SH1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Intraventricular Septal Defects

ArticleYear
A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England.
    European journal of clinical pharmacology, 2004, Volume: 60, Issue:9

    Topics: Adolescent; Adult; Amphetamines; Birth Weight; Case-Control Studies; Cohort Studies; Drug-Related Si

2004